Parkinson Disease Clinical Trial
Official title:
Imaging the Motor System in Parkinson's Disease
Verified date | May 2024 |
Source | University of Delaware |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
The study uses magnetic resonance imaging (MRI) to better understand changes in the brain underlying motor symptoms affecting upper and lower limbs in Parkinson's disease.
Status | Active, not recruiting |
Enrollment | 40 |
Est. completion date | November 2, 2024 |
Est. primary completion date | November 2, 2022 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 45 Years to 85 Years |
Eligibility | Inclusion Criteria: - A clinical diagnosis of Parkinson's disease - No neurological disorders if interested in participating as a control participant - Must be capable of providing informed consent - Must be eligible to receive a brain MRI Exclusion Criteria: - A secondary movement disorder diagnosis in addition to Parkinson's disease - Dementia - Medical conditions that may make one ineligible for receiving a brain MRI - Inability to provide informed consent - Control/healthy group: neurological disorders - Control/healthy group: cannot walk without an assistive device/mobility problems |
Country | Name | City | State |
---|---|---|---|
United States | University of Delaware | Newark | Delaware |
Lead Sponsor | Collaborator |
---|---|
University of Delaware |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Functional MRI activity during a motor task | Functional MRI activity during isolated/coordinated movements of the upper and lower limbs | Baseline | |
Secondary | Movement Disorder Society Unified Parkinson's Disease Rating Scale | Only the motor section will be scored. Maximum points: 84 (the higher the score, the more severe the motor symptoms) | Baseline | |
Secondary | Kinesia One | Instrumented measures of motor dysfunction in Parkinson's disease. Maximum points: 72 (the higher the score, the more severe the motor symptoms) | Baseline | |
Secondary | Timed Up and Go | Mobility test (instrumented). Measures: duration (s), lean angle during sit/stand (degrees), turning duration (s) and turning angle (degrees) | Baseline | |
Secondary | 360-Degree Turn Test | Instrumented test measuring dynamic balance. Measures: turning angle (degrees), turning duration (s), turning velocity (degrees/s) | Baseline | |
Secondary | Five Times Sit to Stand | Instrumented test measuring ability to perform transitional movements (i.e., get up from a chair). Measures: Duration (s), duration of the different phases (sitting/standing) (s), lean angle during the two phases (sitting/standing) (degrees) | Baseline | |
Secondary | The Modified Clinical Test of Sensory Interaction and Balance (mCTSIB) | Instrumented test assessing balance under different test conditions (eyes open/closed on firm/foam surface). Measures of postural sway: sway area (m^2/s^4), jerk (m^2/s^5), mean velocity (m/s), path length (m/s^2) | Baseline | |
Secondary | 2-Minute Walking Test | Instrument test assessing gait under three different conditions: 1) self-selected/normal speed, 2) self-selective/normal speed + cognitive task, 3) fast speed. Measures calculated for each condition/side of body: cadence (steps/min), double support (%GCT), gait cycle duration (s), gait speed (m/s), lateral step variability (cm), toe off angle (degrees), foot strike angle (degrees), turn velocity (degrees/s), upper limb range of motion (degrees), arm swing velocity (degrees/s). | Baseline. | |
Secondary | Purdue Pegboard Test | Test measuring dexterity by counting the number of pegs placed on the pegboard during a given time. | Baseline | |
Secondary | Grooved Pegboard | Test measuring dexterity by counting how long it takes to place a given number of pegs on the pegboard. | Baseline | |
Secondary | Montreal Cognitive Assessment Test | Test measuring global cognitive function. Maximum points: 30 (the higher the score, the better the cognitive function) | Baseline | |
Secondary | Brief Test of Attention | Test measuring attention. Two sections are used that evaluate attention during reading of lists of letters and numbers. Maximum points across the two sections: 20 (the higher the score, the better the attention) | Baseline | |
Secondary | Beck Depression Inventory II | Questionnaire measuring depression. Maximum points: 63 (high score indicates depression) | Baseline | |
Secondary | Parkinson's Disease Questionnaire (PDQ-39) | Questionnaire measure health-related quality of life. Eight dimensions ranging from 0-100 (the higher the score, the worse the quality of life) | Baseline | |
Secondary | Schwab and England Activities of Daily Living Scale | Questionnaire on ability to complete daily task. 10% increments with 100% meaning an individual is completely independent when it comes to completing daily activities | Baseline | |
Secondary | Rapid Eye Movement Behavior Disorder Questionnaire | Questionnaire measuring sleep behavior. Maximum points: 13 (a high score is indicative of RBD sleep disorder) | Baseline | |
Secondary | Epworth Sleepiness Scale | Questionnaire measuring sleepiness. Maximum points: 24 (high score indicates sleepiness) | Baseline | |
Secondary | University of Pennsylvania Smell Identification Test | Test measuring sense of smell. Maximum points: 40 (the higher the score, the more normal the smell) | Baseline |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05415774 -
Combined Deep Brain Stimulation in Parkinson's Disease
|
N/A | |
Recruiting |
NCT04691661 -
Safety, Tolerability, Pharmacokinetics and Efficacy Study of Radotinib in Parkinson's Disease
|
Phase 2 | |
Active, not recruiting |
NCT05754086 -
A Multidimensional Study on Articulation Deficits in Parkinsons Disease
|
||
Completed |
NCT04045925 -
Feasibility Study of the Taïso Practice in Parkinson's Disease
|
N/A | |
Recruiting |
NCT04194762 -
PARK-FIT. Treadmill vs Cycling in Parkinson´s Disease. Definition of the Most Effective Model in Gait Reeducation
|
N/A | |
Completed |
NCT02705755 -
TD-9855 Phase 2 in Neurogenic Orthostatic Hypotension (nOH)
|
Phase 2 | |
Terminated |
NCT03052712 -
Validation and Standardization of a Battery Evaluation of the Socio-emotional Functions in Various Neurological Pathologies
|
N/A | |
Recruiting |
NCT05830253 -
Free-living Monitoring of Parkinson's Disease Using Smart Objects
|
||
Recruiting |
NCT03272230 -
Assessment of Apathy in a Real-life Situation, With a Video and Sensors-based System
|
N/A | |
Recruiting |
NCT06139965 -
Validity and Reliability of the Turkish Version of the Comprehensive Coordination Scale in Parkinson's Patients
|
||
Completed |
NCT04580849 -
Telerehabilitation Using a Dance Intervention in People With Parkinson's Disease
|
N/A | |
Completed |
NCT03980418 -
Evaluation of a Semiconductor Camera for the DaTSCAN™ Exam
|
N/A | |
Completed |
NCT04477161 -
Effect of Ketone Esters in Parkinson's Disease
|
N/A | |
Completed |
NCT04942392 -
Digital Dance for People With Parkinson's Disease During the COVID-19 Pandemic
|
N/A | |
Terminated |
NCT03446833 -
LFP Beta aDBS Feasibility Study
|
N/A | |
Completed |
NCT03497884 -
Individualized Precise Localization of rTMS on Primary Motor Area
|
N/A | |
Completed |
NCT05538455 -
Investigating ProCare4Life Impact on Quality of Life of Elderly Subjects With Neurodegenerative Diseases
|
N/A | |
Recruiting |
NCT04997642 -
Parkinson's Disease and Movement Disorders Clinical Database
|
||
Completed |
NCT04117737 -
A Pilot Study of Virtual Reality and Antigravity Treadmill for Gait Improvement in Parkinson
|
N/A | |
Recruiting |
NCT03618901 -
Rock Steady Boxing vs. Sensory Attention Focused Exercise
|
N/A |